Solstein Capital, LLC Dexcom Inc Transaction History

Solstein Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $21,008 - $41,063	309 Added 300.0%	412 $31,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $8,733 - $10,788	103 New	103 $37,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $8,034 - $10,763	-103 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$36.62 - $57.29 $3,771 - $5,900	103 New	103 $23,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Solstein Capital, LLC with notifications on news.